Life sciences supply chains operate in a zero-failure environment. Regulatory complexity, expiry risk, outsourced manufacturing networks, pricing pressure, M&A activity, and volatile global policy create a constant state of disruption. Yet the expectation remains unchanged: no missed doses, no compliance lapses, no delays to patients.
The organizations that will lead in this environment are not those that eliminate chaos, but those that adapt to it.
In this masterclass, Kinaxis and Octapharma explore what it truly takes to build an adaptive, end-to-end enterprise orchestration approach, spanning clinical, production, and supplier collaboration. Attendees will walk away with three practical, actionable imperatives:
1. Start with data discipline: why data cleanliness and governance are the single most important precursors to any transformation initiative.
2. Prepare for AI the right way: beyond hype, what agentic AI requires in terms of decision rules, workflows, and change management.
3. Master the clinical-to-commercial handoff: how a clean transition reduces risk, protects patient service, and unlocks speed-to-market value.
Through real-world experience and customer perspective from Fabien Huyghe of Octapharma, this session moves beyond theory into what actually works in high-stakes, regulated environments.
Attendees will leave with a framework to confidently lead their organizations through uncertainty, turning disruption into decisive, value-driven action.